Company Filing History:
Years Active: 1994-2025
Title: Carla Labruzzo: Innovator in Pharmaceutical Formulations
Introduction
Carla Labruzzo is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid formulations for mesalazine. With a total of 6 patents to her name, her work has had a considerable impact on the treatment of chronic inflammatory pathologies.
Latest Patents
One of her latest patents focuses on a process for mesalazine solid formulations. This invention relates to preparing solid pharmaceutical forms that contain a quantity of mesalazine ranging from 75% to 95%, equating to between 1000 and 1600 mg of the drug per dosage unit. The patent also describes the granulate and/or tablets produced through this process, which are preferably coated to allow for the controlled release of the drug. Furthermore, the invention emphasizes the use of these granulates and tablets as medicaments, particularly for treating chronic inflammatory conditions affecting the intestinal tract.
Career Highlights
Throughout her career, Carla has worked with notable companies in the pharmaceutical industry, including Sofar S.p.a. and Alfasigma S.p.a. Her experience in these organizations has contributed to her expertise in pharmaceutical formulations and innovation.
Collaborations
Carla has collaborated with various professionals in her field, including her coworker Antonio Mannello. These collaborations have further enriched her work and expanded her contributions to pharmaceutical science.
Conclusion
Carla Labruzzo stands out as an influential inventor in the pharmaceutical industry, with her innovative approaches to mesalazine formulations paving the way for advancements in treatment options. Her dedication to improving healthcare through her inventions is commendable and continues to inspire future innovations.